Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Brigitte Bisaro"'
Autor:
Maria del Pilar Camacho Leal, Alessandra Pincini, Giusy Tornillo, Elisa Fiorito, Brigitte Bisaro, Elisa Di Luca, Emilia Turco, Paola Defilippi, Sara Cabodi
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e49817 (2012)
p130Cas adaptor protein regulates basic processes such as cell cycle control, survival and migration. p130Cas over-expression has been related to mammary gland transformation, however the in vivo consequences of p130Cas over-expression during mammary
Externí odkaz:
https://doaj.org/article/24197419f6fb486ba33fe11095f216b0
Autor:
Cristina Marchini, Maura Montani, Georgia Konstantinidou, Rita Orrù, Silvia Mannucci, Giorgio Ramadori, Federico Gabrielli, Anna Baruzzi, Giorgio Berton, Flavia Merigo, Stefania Fin, Manuela Iezzi, Brigitte Bisaro, Andrea Sbarbati, Massimo Zerani, Mirco Galiè, Augusto Amici
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e14131 (2010)
BackgroundMounting clinical and experimental evidence suggests that the shift of carcinomas towards a mesenchymal phenotype is a common paradigm for both resistance to therapy and tumor recurrence. However, the mesenchymalization of carcinomas has no
Externí odkaz:
https://doaj.org/article/950ce2c2c1144253a2591cb5960aa677
Autor:
Silvia Mattia, Antonio Marmotti, Federico Mussano, Brigitte Bisaro, Cristina Zanini, Marco Forni
Publikováno v:
Journal of Evolving Stem Cell Research. 1:24-34
Autor:
Filippo Montemurro, Maria del Pilar Camacho Leal, Marianna Sciortino, Giorgio Valabrega, Shana Colombo, Brigitte Bisaro, Paola Defilippi, Andrea Costamagna, Emilia Turco, Isabella Castellano, Sara Cabodi, Valentina Rossi
Publikováno v:
Oncotarget
Overexpression of the ErbB2/HER2 receptor tyrosine kinase occurs in up to 20% of human breast cancers and correlates with aggressive disease. Several efficacious targeted therapies, including antibodies and kinase inhibitors, have been developed but
Autor:
Giorgia Mandili, Franco Turrini, Luca Cordero di Montezemolo, Alessandra Doria, Brigitte Bisaro, Franco Carta, Nicoletta Crescenzio, Fabio Timeus, Cristina Zanini, Luiselda Foglia, Giuliana Giribaldi
Publikováno v:
Journal of Neurochemistry. 103:1344-1354
Neuroblastoma (NB) and Ewing's sarcoma (ES) represent the most common extracranial solid tumors of childhood. Heat shock proteins (HSP) are elevated in cancer cells and their over-expression was correlated to drug-resistance. In this work we identifi
Autor:
Katia Rea, Marialuisa Sensi, Federica Alciato, Antonella Tomassetti, Ludmila Lozneanu, Sara Cabodi, Patrizia Pinciroli, Brigitte Bisaro, Francesco Raspagliesi, Gian Carlo Avanzi, Silvana Canevari, Paola Defilippi, Floriana Centritto
Publikováno v:
Oncotarget
High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e858012a435189bdc8ef05457359936
http://hdl.handle.net/2318/1526388
http://hdl.handle.net/2318/1526388
Autor:
Brigitte Bisaro, Andrea Piolatto, Giovanna Cenacchi, Cristina Zanini, Giorgia Mandili, Alice Poli, Francesco Novelli, Valentina Papa, Marco Forni
Publikováno v:
Molecular and cellular therapies
Background Medulloblastoma (MB) is the most common malignant childhood brain tumor with the propensity to disseminate at an early stage, and is associated with high morbidity. New treatment strategies are needed to improve cure rates and to reduce li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9745733c8b04381ce0b63e9725895bf0
http://hdl.handle.net/2318/1621514
http://hdl.handle.net/2318/1621514
Autor:
Brigitte Bisaro, Francesca Orso, Maria del Pilar Camacho Leal, Antonio Lembo, Sara Cabodi, Paolo Provero, Enzo Medico, Emilia Turco, Cristiano De Pittà, Marianna Sciortino, Paola Defilippi, Giusy Tornillo, Maria Felice Brizzi, Daniela Taverna, Alessandra Pincini
Understanding transcriptional changes during cancer progression is of crucial importance to develop new and more efficacious diagnostic and therapeutic approaches. It is well known that ErbB2 is overexpressed in about 25% of human invasive breast can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9beb21b16876d766465a9e2fd3ee1b43
http://hdl.handle.net/2318/136504
http://hdl.handle.net/2318/136504
Autor:
Manuela Iezzi, Francesca Orso, Georgia Konstantinidou, Brigitte Bisaro, Shana Colombo, Emilia Turco, Cristina Marchini, Paola Defilippi, Maria del Pilar Camacho-Leal, Giusy Tornillo, Annalisa Camporeale, Maura Montani, Sara Cabodi, Augusto Amici, Lucia Pietrella, Mirco Galiè, Paola Di Stefano, Daniela Taverna
Publikováno v:
Bisaro, Brigitte; Montani, Maura; Konstantinidou, Georgia; Marchini, Cristina; Pietrella, Lucia; Iezzi, Manuela; Galiè, Mirco; Orso, Francesca; Camporeale, Annalisa; Colombo, Shana M; Di Stefano, Paola; Tornillo, Giusy; Camacho-Leal, Maria P; Turco, Emilia; Taverna, Daniela; Cabodi, Sara; Amici, Augusto; Defilippi, Paola (2012). p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells. Breast cancer research, 14(5), R137. BioMed Central Ltd. 10.1186/bcr3342
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Introduction Intrinsic plasticity of breast carcinoma cells allows them to undergo a transient and reversible conversion into mesenchymal cells to disseminate into distant organs, where they can re-differentiate to an epithelial-like status to form a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edd91eab7664beea80736b14089211c
https://boris.unibe.ch/96848/1/document.pdf
https://boris.unibe.ch/96848/1/document.pdf